DOI QR코드

DOI QR Code

The expression of a nitric oxide derivative, tissue inhibitors of metalloproteinase-3, and tissue inhibitors of metalloproteinase-4 in chronic periodontitis with type 2 diabetes mellitus

  • Jung, Hyun-Yub (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Kim, Yong-Gun (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Park, Jin-Woo (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Suh, Jo-Young (Department of Periodontology, Kyungpook National University School of Dentistry) ;
  • Lee, Jae-Mok (Department of Periodontology, Kyungpook National University School of Dentistry)
  • Received : 2012.12.20
  • Accepted : 2013.03.10
  • Published : 2013.04.30

Abstract

Purpose: The purpose of this study was to analyze the expression of inducible nitric oxide synthases (iNOS), tissue inhibitors of metalloproteinase $(TIMP)_{-3}$, and $TIMP_{-4}$ in the gingival tissues of periodontal patients with or without type 2 diabetes mellitus (DM). Methods: Depending on the patient's systemic condition and clinical criteria of the gingiva, each gingival sample was classified into one of three groups. Sixteen clinically, systemically healthy patients (group 1), 16 periodontal patients (group 2), and 16 periodontal patients with DM (group 3) were included. Tissue samples in each group were collected, prepared, and analyzed by western blotting. Quantification of the relative amount of $TIMP_{-3}$, $TIMP_{-4}$, and iNOS was performed. Results: The expression levels of iNOS and $TIMP_{-3}$ both increased in group 1, group 2, and group 3 in increasing order, and were significantly higher in both group 2 and group 3 as compared to group 1 (P<0.05). The expression levels of $TIMP_{-4}$ increased in the same order, but significantly increased in group 2 as compared to group 1, in group 3 as compared to group 1, and group 3 as compared to group 2 (P<0.05). Conclusions: This study demonstrated that iNOS, $TIMP_{-3}$, and $TIMP_{-4}$ might be involved in the progression of periodontal inflammation associated with type 2 DM. It is thought that further study of these factors can be applied practically for the diagnosis and control of periodontitis in diabetics.

Keywords

References

  1. Eley BM, Cox SW. Proteolytic and hydrolytic enzymes from putative periodontal pathogens: characterization, molecular genetics, effects on host defenses and tissues and detection in gingival crevice fluid. Periodontol 2000 2003;31:105-24. https://doi.org/10.1034/j.1600-0757.2003.03107.x
  2. Hou YC, Janczuk A, Wang PG. Current trends in the development of nitric oxide donors. Curr Pharm Des 1999;5: 417-41.
  3. Batista AC, Silva TA, Chun JH, Lara VS. Nitric oxide synthesis and severity of human periodontal disease. Oral Dis 2002;8:254-60. https://doi.org/10.1034/j.1601-0825.2002.02852.x
  4. Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 2001;15:831-45. https://doi.org/10.1053/berh.2001.0196
  5. Reher VG, Zenobio EG, Costa FO, Reher P, Soares RV. Nitric oxide levels in saliva increase with severity of chronic periodontitis. J Oral Sci 2007;49:271-6. https://doi.org/10.2334/josnusd.49.271
  6. Kendall HK, Marshall RI, Bartold PM. Nitric oxide and tissue destruction. Oral Dis 2001;7:2-10. https://doi.org/10.1034/j.1601-0825.2001.70102.x
  7. Bauer EA, Stricklin GP, Jeffrey JJ, Eisen AZ. Collagenase production by human skin fibroblasts. Biochem Biophys Res Commun 1975;64:232-40. https://doi.org/10.1016/0006-291X(75)90243-0
  8. Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111-22.
  9. Young DA, Phillips BW, Lundy C, Nuttall RK, Hogan A, Schultz GA, et al. Identification of an initiator-like element essential for the expression of the tissue inhibitor of metalloproteinases-4 (Timp-4) gene. Biochem J 2002;364(Pt 1):89-99. https://doi.org/10.1042/bj3640089
  10. Muhlemann HR, Son S. Gingival sulcus bleeding: a leading symptom in initial gingivitis. Helv Odontol Acta 1971; 15:107-13.
  11. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26 Suppl 1:S5-20. https://doi.org/10.2337/diacare.26.2007.S5
  12. Cho JY, Xing S, Liu X, Buckwalter TL, Hwa L, Sferra TJ, et al. Expression and activity of human Na+/I- symporter in human glioma cells by adenovirus-mediated gene delivery. Gene Ther 2000;7:740-9.
  13. Stefanovic-Racic M, Stadler J, Evans CH. Nitric oxide and arthritis. Arthritis Rheum 1993;36:1036-44. https://doi.org/10.1002/art.1780360803
  14. Allaker RP, Silva Mendez LS, Hardie JM, Benjamin N. Antimicrobial effect of acidified nitrite on periodontal bacteria. Oral Microbiol Immunol 2001;16:253-6. https://doi.org/10.1034/j.1399-302X.2001.160410.x
  15. Gyurko R, Boustany G, Huang PL, Kantarci A, Van Dyke TE, Genco CA, et al. Mice lacking inducible nitric oxide synthase demonstrate impaired killing of Porphyromonas gingivalis. Infect Immun 2003;71:4917-24. https://doi.org/10.1128/IAI.71.9.4917-4924.2003
  16. Ralston SH, Todd D, Helfrich M, Benjamin N, Grabowski PS. Human osteoblast-like cells produce nitric oxide and express inducible nitric oxide synthase. Endocrinology 1994;135:330-6. https://doi.org/10.1210/endo.135.1.7516867
  17. van't Hof RJ, Ralston SH. Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity. J Bone Miner Res 1997;12:1797-804. https://doi.org/10.1359/jbmr.1997.12.11.1797
  18. Lohinai Z, Benedek P, Feher E, Gyorfi A, Rosivall L, Fazekas A, et al. Protective effects of mercaptoethylguanidine, a selective inhibitor of inducible nitric oxide synthase, in ligature-induced periodontitis in the rat. Br J Pharmacol 1998;123:353-60. https://doi.org/10.1038/sj.bjp.0701604
  19. Leitao RF, Ribeiro RA, Chaves HV, Rocha FA, Lima V, Brito GA. Nitric oxide synthase inhibition prevents alveolar bone resorption in experimental periodontitis in rats. J Periodontol 2005;76:956-63. https://doi.org/10.1902/jop.2005.76.6.956
  20. Lin SK, Kok SH, Kuo MY, Lee MS, Wang CC, Lan WH, et al. Nitric oxide promotes infectious bone resorption by enhancing cytokine-stimulated interstitial collagenase synthesis in osteoblasts. J Bone Miner Res 2003;18:39-46. https://doi.org/10.1359/jbmr.2003.18.1.39
  21. Alayan J, Ivanovski S, Gemmell E, Ford P, Hamlet S, Farah CS. Deficiency of iNOS contributes to Porphyromonas gingivalis-induced tissue damage. Oral Microbiol Immunol 2006;21:360-5. https://doi.org/10.1111/j.1399-302X.2006.00304.x
  22. Takahashi Y, Nakano T, Wakabayashi I. Increased induction of inducible nitric oxide synthase expression in aortae of type 2 diabetes rats. J Pharmacol Sci 2008;107:190-200. https://doi.org/10.1254/jphs.FP0080010
  23. Pereira FO, Frode TS, Medeiros YS. Evaluation of tumour necrosis factor alpha, interleukin-2 soluble receptor, nitric oxide metabolites, and lipids as inflammatory markers in type 2 diabetes mellitus. Mediators Inflamm 2006;2006: 39062.
  24. Nagareddy PR, McNeill JH, MacLeod KM. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats. Eur J Pharmacol 2009;611:53-9. https://doi.org/10.1016/j.ejphar.2009.03.061
  25. Kashyap SR, Roman LJ, Lamont J, Masters BS, Bajaj M, Suraamornkul S, et al. Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects. J Clin Endocrinol Metab 2005; 90:1100-5. https://doi.org/10.1210/jc.2004-0745
  26. Lappin DF, Kjeldsen M, Sander L, Kinane DF. Inducible nitric oxide synthase expression in periodontitis. J Periodontal Res 2000;35:369-73. https://doi.org/10.1034/j.1600-0765.2000.035006369.x
  27. Nishikawa T, Naruse K, Kobayashi Y, Miyajima S, Mizutani M, Kikuchi T, et al. Involvement of nitrosative stress in experimental periodontitis in diabetic rats. J Clin Periodontol 2012;39:342-9. https://doi.org/10.1111/j.1600-051X.2011.01848.x
  28. Garlet GP, Cardoso CR, Campanelli AP, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. The dual role of p55 tumour necrosis factor-alpha receptor in Actinobacillus actinomycetemcomitans-induced experimental periodontitis: host protection and tissue destruction. Clin Exp Immunol 2007;147:128-38.
  29. Garlet GP, Martins W Jr, Fonseca BA, Ferreira BR, Silva JS. Matrix metalloproteinases, their physiological inhibitors and osteoclast factors are differentially regulated by the cytokine profile in human periodontal disease. J Clin Periodontol 2004;31:671-9. https://doi.org/10.1111/j.1600-051X.2004.00545.x
  30. Kubota T, Itagaki M, Hoshino C, Nagata M, Morozumi T, Kobayashi T, et al. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue. J Periodontol 2008;79:166-73. https://doi.org/10.1902/jop.2008.070159
  31. Nakasone N, Kubota T, Hoshino C, Nohno K, Itagaki M, Shimizu T, et al. Differential gene and protein expression of tissue inhibitors of metalloproteinases (TIMP)-3 and TIMP-4 in gingival tissues from drug induced gingival overgrowth. Arch Oral Biol 2009;54:634-41. https://doi.org/10.1016/j.archoralbio.2009.04.002
  32. Claudino M, Trombone AP, Cardoso CR, Ferreira SB Jr, Martins W Jr, Assis GF, et al. The broad effects of the functional IL-10 promoter-592 polymorphism: modulation of IL-10, TIMP-3, and OPG expression and their association with periodontal disease outcome. J Leukoc Biol 2008;84: 1565-73. https://doi.org/10.1189/jlb.0308184
  33. Nagase H, Woessner JF Jr. Matrix metalloproteinases. J Biol Chem 1999;274:21491-4. https://doi.org/10.1074/jbc.274.31.21491
  34. Garlet GP, Cardoso CR, Silva TA, Ferreira BR, Avila-Campos MJ, Cunha FQ, et al. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors. Oral Microbiol Immunol 2006;21:12-20. https://doi.org/10.1111/j.1399-302X.2005.00245.x
  35. Cochran DL. Inflammation and bone loss in periodontal disease. J Periodontol 2008;79(8 Suppl):1569-76. https://doi.org/10.1902/jop.2008.080233
  36. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, et al. TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998;435:39-44. https://doi.org/10.1016/S0014-5793(98)01031-X
  37. Monroy A, Kamath S, Chavez AO, Centonze VE, Veerasamy M, Barrentine A, et al. Impaired regulation of the TNF-alpha converting enzyme/tissue inhibitor of metalloproteinase 3 proteolytic system in skeletal muscle of obese type 2 diabetic patients: a new mechanism of insulin resistance in humans. Diabetologia 2009;52:2169-81. https://doi.org/10.1007/s00125-009-1451-3
  38. Cardellini M, Menghini R, Martelli E, Casagrande V, Marino A, Rizza S, et al. TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 2009;58:2396-401. https://doi.org/10.2337/db09-0280
  39. Koskivirta I, Rahkonen O, Mayranpaa M, Pakkanen S, Husheem M, Sainio A, et al. Tissue inhibitor of metalloproteinases 4 (TIMP4) is involved in inflammatory processes of human cardiovascular pathology. Histochem Cell Biol 2006;126:335-42. https://doi.org/10.1007/s00418-006-0163-8

Cited by

  1. Lead Intoxication Under Environmental Hypoxia Impairs Oral Health vol.77, pp.21, 2014, https://doi.org/10.1080/15287394.2014.938209
  2. 웰니스 및 구강질환억제를 위한 천연물 유래물질 연구 vol.13, pp.5, 2013, https://doi.org/10.14400/jdc.2015.13.5.357
  3. Local inflammatory reactions in patients with diabetes and periodontitis vol.69, pp.1, 2013, https://doi.org/10.1111/prd.12089
  4. Interrelation between plasma membrane calcium ATPase-1 and inflammatory mediators expression in gingival tissue depending on severity of periodontitis vol.44, pp.1, 2020, https://doi.org/10.21851/obr.44.01.202003.23
  5. Evaluation of superoxide dismutase 3, heme-oxygenase, and myeloperoxidase expression levels associated with oxidative stress in chronic periodontitis vol.45, pp.3, 2013, https://doi.org/10.21851/obr.45.03.202109.99